La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Vineet Laboratories Salute del bilancio

Salute finanziaria criteri di controllo 2/6

Vineet Laboratories ha un patrimonio netto totale di ₹325.9M e un debito totale di ₹423.4M, che porta il suo rapporto debito/patrimonio netto a 129.9%. Le sue attività totali e le sue passività totali sono rispettivamente ₹1.1B e ₹785.1M. L'EBIT di Vineet Laboratories è ₹36.3M rendendo il suo rapporto di copertura degli interessi 0.7. Ha liquidità e investimenti a breve termine pari a ₹14.6M.

Informazioni chiave

129.9%

Rapporto debito/patrimonio netto

₹423.40m

Debito

Indice di copertura degli interessi	0.7x
Contanti	₹14.55m
Patrimonio netto	₹325.94m
Totale passività	₹785.14m
Totale attività	₹1.11b

Aggiornamenti recenti sulla salute finanziaria

Vineet Laboratories (NSE:VINEETLAB) Seems To Be Using A Lot Of Debt

Jul 12

We Think Vineet Laboratories (NSE:VINEETLAB) Is Taking Some Risk With Its Debt

Feb 15

Recent updates

Vineet Laboratories (NSE:VINEETLAB) Seems To Be Using A Lot Of Debt

Jul 12

Earnings Working Against Vineet Laboratories Limited's (NSE:VINEETLAB) Share Price Following 25% Dive

Mar 07

We Think Vineet Laboratories (NSE:VINEETLAB) Is Taking Some Risk With Its Debt

Feb 15

With EPS Growth And More, Vineet Laboratories (NSE:VINEETLAB) Makes An Interesting Case

Nov 14

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( ₹828.0M ) di VINEETLAB superano le sue passività a breve termine ( ₹709.5M ).

Passività a lungo termine: Le attività a breve termine di VINEETLAB ( ₹828.0M ) superano le sue passività a lungo termine ( ₹75.6M ).

Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: Il rapporto debito netto/patrimonio netto ( 125.4% ) di VINEETLAB è considerato alto.

Riduzione del debito: Dati insufficienti per determinare se il rapporto debito/patrimonio netto di VINEETLAB si sia ridotto negli ultimi 5 anni.

Copertura del debito: Il flusso di cassa operativo di VINEETLAB è negativo, pertanto il debito non è ben coperto.

Copertura degli interessi: I pagamenti degli interessi sul debito di VINEETLAB non sono ben coperti dall'EBIT ( 0.7 x copertura).

Vineet Laboratories Salute del bilancio

Salute finanziaria criteri di controllo 2/6

Informazioni chiave

Aggiornamenti recenti sulla salute finanziaria

Vineet Laboratories (NSE:VINEETLAB) Seems To Be Using A Lot Of Debt

We Think Vineet Laboratories (NSE:VINEETLAB) Is Taking Some Risk With Its Debt

Recent updates

Vineet Laboratories Limited, Annual General Meeting, Sep 27, 2024

First quarter 2025 earnings released: ₹2.31 loss per share (vs ₹1.36 loss in 1Q 2024)

Vineet Laboratories Limited to Report Q1, 2025 Results on Aug 13, 2024

Investor sentiment improves as stock rises 20%

Vineet Laboratories (NSE:VINEETLAB) Seems To Be Using A Lot Of Debt

Full year 2024 earnings released: EPS: ₹1.11 (vs ₹1.36 in FY 2023)

Vineet Laboratories Limited Announces Resignation of Satish Pandurang Samant as Executive Director

New minor risk - Share price stability

Vineet Laboratories Limited to Report Q4, 2024 Results on May 29, 2024

Investor sentiment improves as stock rises 19%

Earnings Working Against Vineet Laboratories Limited's (NSE:VINEETLAB) Share Price Following 25% Dive

We Think Vineet Laboratories (NSE:VINEETLAB) Is Taking Some Risk With Its Debt

Third quarter 2024 earnings released: ₹2.22 loss per share (vs ₹1.51 profit in 3Q 2023)

Vineet Laboratories Limited to Report Q3, 2024 Results on Feb 12, 2024

Investor sentiment improves as stock rises 21%

Investor sentiment improves as stock rises 32%

With EPS Growth And More, Vineet Laboratories (NSE:VINEETLAB) Makes An Interesting Case

New minor risk - Share price stability

Second quarter 2024 earnings released: EPS: ₹2.62 (vs ₹5.10 loss in 2Q 2023)

Vineet Laboratories Limited Announces Appointment of Mr. Rameshkumar Bandari as Company Secretary and Compliance Officer

Vineet Laboratories Limited to Report Q2, 2024 Results on Nov 10, 2023

Vineet Laboratories Limited Announces Resignation of Nirosha Ravikanti as Company Secretary / Compliance Officer of the Company

Vineet Laboratories Limited Appoints Mr. Satish Pandurang Samant as Chief Executive Officer

Vineet Laboratories Limited Appoints Mr. Satish Pandurang Samant as Chief Executive Officer

Vineet Laboratories Limited, Annual General Meeting, Sep 28, 2023

Vineet Laboratories Limited Announces Board Changes

New major risk - Revenue and earnings growth

First quarter 2024 earnings released: ₹1.36 loss per share (vs ₹1.10 profit in 1Q 2023)

Investor sentiment improves as stock rises 22%

Vineet Laboratories Limited to Report Q1, 2024 Results on Aug 12, 2023

Full year 2023 earnings released: EPS: ₹1.36 (vs ₹7.20 in FY 2022)

Vineet Laboratories Limited to Report Q4, 2023 Results on May 29, 2023

Investor sentiment improves as stock rises 23%

MD & Director recently bought ₹333k worth of stock

MD & Director recently bought ₹416k worth of stock

MD & Director recently bought ₹868k worth of stock

MD & Director recently bought ₹430k worth of stock

Investor sentiment deteriorates as stock falls 16%

Third quarter 2023 earnings released: EPS: ₹1.51 (vs ₹3.52 in 3Q 2022)

Vineet Laboratories Limited to Report Q3, 2023 Results on Feb 14, 2023

Investor sentiment improved over the past week

Second quarter 2023 earnings released: ₹5.10 loss per share (vs ₹3.52 profit in 2Q 2022)

High number of new and inexperienced directors

Vineet Laboratories Limited Approves Change the Designation of Kandula Murali Mohan from Non- Executive Director to Whole Time Director

Vineet Laboratories Limited, Annual General Meeting, Sep 28, 2022

First quarter 2023 earnings released: EPS: ₹1.10 (vs ₹2.18 in 1Q 2022)

Vineet Laboratories Limited Appoints Mrs. Yerukalapudi Hari Priya as Additional Independent Director (Non-Executive)

Vineet Laboratories Limited to Report Q1, 2023 Results on Jul 29, 2022

Vineet Laboratories Limited Announces Resignation of Thotakura Uma Sangeetha as Independent Director

Investor sentiment improved over the past week

Vineet Laboratories Limited Recommends Final Dividend for the Financial Year Ended March 31, 2022

Vineet Laboratories Limited to Report Q4, 2022 Results on May 28, 2022

Investor sentiment improved over the past week

High number of new and inexperienced directors

Investor sentiment improved over the past week

High number of new and inexperienced directors

Analisi della posizione finanziaria

Storia e analisi del rapporto debito/patrimonio netto

Bilancio

Scoprire le aziende sane